Author | Sara Hurvitz, MD | OncLive

Author | Sara Hurvitz, MD

Articles

Dr. Hurvitz on the Potential Global Impact of Biosimilars in Breast Cancer

August 23, 2019

Video

Sara Hurvitz, MD, associate professor, David Geffen School of Medicine, UCLA; medical director, Jonsson Comprehensive Cancer Center Clinical Research Unit; co-director, Santa Monica-UCLA Outpatient Oncology Practices; and director, Breast Cancer Clinical Trials Program, UCLA, discusses the potential global impact of biosimilars in breast cancer.

Dr. Hurvitz on the FDA Approval Process for Biosimilars

April 30, 2018

Video

Sara Hurvitz, MD, director of the Breast Oncology Program, medical director of the Clinical Research Unit, University of California, Los Angeles Jonsson Comprehensive Cancer Center, discusses when to use a biosimilar over the originator drug.

Dr. Hurvitz on Biosimilars in Breast Cancer

April 23, 2018

Video

Sara Hurvitz, MD, director of the Breast Oncology Program, medical director of the Clinical Research Unit, University of California, Los Angeles Jonsson Comprehensive Cancer Center, discusses biosimilars in breast cancer.

Dr. Hurvitz on Treatment Options for HER2-Positive Breast Cancer

June 02, 2017

Video

Sara Hurvitz, MD, Associate Professor of Medicine at UCLA, discusses treatment options for patients with HER2-positive breast cancer.

x